New implantable system can manipulate brain signals and suppress pathological coupling

As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease. But current approaches to designing a fully implantable and biocompatible device able to make such interventions have major limitations: their resolution isn't high enough and most require […]

Read more

Task Force Tackles FDA Lamotrigine Cardiac Risk Warning

A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) warning of cardiac risk in patients taking the antiseizure drug lamotrigine. The task force is concerned that the FDA warning is based on data not yet widely available, and […]

Read more

Tailor-made drugs to treat epilepsy or cardiovascular diseases

In order for a drug to be effective at the right places in the body, it helps if scientists can predict as accurately as possible how the molecules of that drug will interact with human cells. In a joint research project, scientists from Collaborative Research Centre 1423 at Leipzig University and the Chinese Academy of Sciences in Shanghai have succeeded […]

Read more

Terry White Chemists Clomipramine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS CLOMIPRAMINE Contains the active ingredient, clomipramine (as clomipramine hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about clomipramine. It does not contain all the available information.It does not take […]

Read more

Oxycodone Mylan

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OXYCODONE MYLAN oxycodone hydrochloride Consumer Medicine Information WARNING Limitations of use OXYCODONE MYLAN should only be used when your doctor decides that other treatment options are not able to effectively manage your pain or you cannot tolerate them. Hazardous and harmful use OXYCODONE MYLAN poses risks of […]

Read more

APO-Sumatriptan

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-SUMATRIPTAN Sumatriptan succinate Consumer Medicine Information   What is in this leaflet This leaflet answers some common questions about sumatriptan. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. […]

Read more

Study highlights failure to recognise risks of epilepsy drug in pregnancy

Doctors are often failing to inform patients about the risk of birth defects to their unborn babies of a commonly used drug to treat epilepsy, according to a literature review by a University of Manchester researcher. The study by Wejdan Shroukh also reveals that both clinical staff and patients can dangerously misjudge the risk of taking a group of drugs—called […]

Read more

People’s motivations bias how they gather information: A person will gather less data before reaching a conclusion they wished was true all along

A new study suggests people stop gathering evidence earlier when the data supports their desired conclusion than when it supports the conclusion they wish was false. Filip Gesiarz, Donal Cahill and Tali Sharot of University College London, U.K. report in PLOS Computational Biology. Previous studies had already provided some clues that people gather less information before reaching desirable beliefs. For […]

Read more

Advancing epilepsy treatment

Researchers at Case Western Reserve University have successfully prevented epileptic seizures in animal models by preemptively directing a low-frequency stimulus to the nerve fibers in the brain. That technique differs substantially from current human therapies recently approved by the U.S. Food and Drug Administration, in which doctors now employ a much higher frequency directly into brain tissue and sometimes only […]

Read more
1 2